Report banner
Home
Industries
Healthcare
Healthcare
report thumbnailEnzyme-Linked Immunosorbent Assays Market

Enzyme-Linked Immunosorbent Assays Market Unlocking Growth Potential: Analysis and Forecasts 2024-2032

Enzyme-Linked Immunosorbent Assays Market by Test Type (Direct ELISA, Sandwich ELISA, Competitive ELISA, Reverse ELISA), by Application (Immunology, Inflammation, Infectious Diseases, Cancer, Protein Quantification), by End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research & Academic Institutions), by North America (U.S., Canada, Mexico), by Europe (UK, Germany, France, Italy, Spain, Russia, Netherlands, Switzerland, Poland, Sweden, Belgium), by Asia Pacific (China, India, Japan, South Korea, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, New Zealand), by Latin America (Brazil, Mexico, Argentina, Chile, Colombia, Peru), by MEA (UAE, Saudi Arabia, South Africa, Egypt, Turkey, Israel, Nigeria, Kenya) Forecast 2024-2032

Oct 11 2024
Base Year: 2023
150 Pages
Market Research Future Logo

Enzyme-Linked Immunosorbent Assays Market Unlocking Growth Potential: Analysis and Forecasts 2024-2032

Key Insights

The global Enzyme-Linked Immunosorbent Assays (ELISA) market size is anticipated to reach USD 15.3 billion by 2027, growing at a CAGR of 19.5% from 2021 to 2027. Enzyme-Linked Immunosorbent Assays (ELISAs) is a very sensitive method of identifying how much of a given protein, peptide, antibody, or hormone is in a solution. ELISAs are adopted in many various areas, from the diagnostics of the diseases to pharmaceutical, food and environmental safety. There are various types of ELISAs differentiated based on the technique such as direct ELISAs, indirect ELISAs, sandwich ELISAs, and competitive ELISAs. m ELISA includes solid phase, target specific reagent by either antibody or antigen, enzyme conjugated reagent by either antibody or antigen, chromogenic substrate and detection system. ELISAs come with many advantages, including sensitivity, specificity, and ease of scaling, which positions them as essential assets to biomedical studies and medical care. Current advances in the medical field include the combined use of ELISAs for various antigens as well as the incorporation of robotics for increased efficiency of the tests.

Enzyme-Linked Immunosorbent Assays Market Research Report - Market Size, Growth & Forecast

Enzyme-Linked Immunosorbent Assays Trends

  • Increasing prevalence of chronic diseases
  • Growing demand for point-of-care testing
  • Technological advancements in ELISA kits and instruments

Driving Forces: What's Propelling the Enzyme-Linked Immunosorbent Assays Market

  • Early detection and diagnosis of diseases: ELISA assays enable the rapid and accurate detection of various biomarkers and antigens associated with diseases, facilitating early diagnosis and timely treatment interventions.
  • Cost-effective and reliable testing methods: ELISA assays are relatively inexpensive compared to other diagnostic techniques, making them accessible to healthcare providers in resource-constrained settings. They also offer high specificity and sensitivity, ensuring reliable results.
  • Versatility of ELISA assays for various applications: ELISA assays can be used in various fields beyond medical diagnostics, including environmental monitoring, food safety, and drug discovery. This versatility expands their market opportunities and drives growth potential.

Challenges and Restraints in Enzyme-Linked Immunosorbent Assays Market

  • Complexity of ELISA protocols: ELISA assays can be technically demanding, requiring specialized equipment and expertise. The multi-step procedures and time-sensitive nature of the protocols present challenges, especially in settings with limited resources and skilled personnel.
  • Time-consuming and labor-intensive procedures: ELISA assays typically require several hours to complete, involving various washing and incubation steps. This can limit their efficiency and throughput in high-volume testing environments.
  • Limited sensitivity in certain applications: Although ELISA assays offer high sensitivity in many applications, they may have limitations in detecting low concentrations of certain analytes. This can be a concern in scenarios where early detection is critical.

Emerging Trends in Enzyme-Linked Immunosorbent Assays

  • Development of multiplex ELISA assays
  • Integration of ELISA with microfluidic platforms
  • Use of artificial intelligence for data analysis

Growth Catalysts in Enzyme-Linked Immunosorbent Assays Industry

  • Government initiatives to improve healthcare infrastructure: Government initiatives aimed at improving access to quality healthcare, such as expanding testing capabilities and supporting diagnostic centers, drive the demand for ELISA assays and contribute to market growth.
  • Rising awareness about personalized medicine: Advances in personalized medicine and the increasing adoption of targeted therapies require precise and reliable diagnostic tools. ELISA assays play a crucial role in identifying biomarkers associated with genetic variations and disease susceptibility, enabling tailored treatment plans.
  • Collaborations between pharmaceutical companies and ELISA kit manufacturers: Partnerships between pharmaceutical companies and ELISA kit manufacturers facilitate the development and commercialization of novel assays tailored to specific disease areas. These collaborations leverage the expertise of both parties to enhance the accuracy, sensitivity, and convenience of ELISA-based diagnostic tests.

Market Segmentation: Enzyme-Linked Immunosorbent Assays Analysis

Test Type:

  • Direct ELISA
  • Sandwich ELISA
  • Competitive ELISA
  • Reverse ELISA

Application:

  • Immunology
  • Inflammation
  • Infectious Diseases
  • Cancer
  • Protein Quantification

End User:

  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutions

Leading Players in the Enzyme-Linked Immunosorbent Assays Market

  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Ortho-Clinical Diagnostics
  • ZEUS Scientific, Inc.
  • BD (Becton, Dickinson and Company)
  • ALPCO
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd
  • Abbott
  • Enzo Life Sciences, Inc.,

Significant developments in Enzyme-Linked Immunosorbent Assays Sector

  • Launch of new high-sensitivity ELISA kits
  • Development of automated ELISA analyzers
  • Strategic acquisitions and partnerships among industry players

Comprehensive Coverage Enzyme-Linked Immunosorbent Assays Market Report

  • Market size and growth rate
  • Key drivers and challenges
  • Emerging trends and innovations
  • Competitive landscape
  • Regional analysis
  • Impact of COVID-19 on the market

Regional Insight

Enzyme-Linked Immunosorbent Assays Market Regional Share
  • North America (the United States, Canada, and Mexico)
  • Europe (Germany, France, the United Kingdom, Italy, and Spain)
  • Asia-Pacific (China, India, Japan, and Australia)
  • South America (Brazil, Argentina, and Colombia)
  • Middle East and Africa (Saudi Arabia, the United Arab Emirates, and South Africa)

DROCT

  • Drivers: Early detection and diagnosis of diseases, cost-effectiveness
  • Restraints: Complexity of protocols, labor-intensive procedures
  • Opportunities: Multiplex ELISA assays, microfluidic integration
  • Challenges: Limited sensitivity in certain applications, regulatory compliance

Pricing Analysis

  • Factors influencing pricing: Kit type, application, manufacturer
  • Price range: $20–$100 per kit
  • Tiered pricing based on volume orders

Import And Export Analysis

  • Major importing regions: North America, Europe
  • Major exporting regions: Asia-Pacific, Europe
  • Trade regulations and tariffs

Segmentation

  • By Product Type: ELISA kits, ELISA instruments, ELISA reagents
  • By Application: Clinical diagnostics, pharmaceutical research, life sciences research
  • By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

Patent/Trademark Analysis

  • Key patents related to ELISA technology
  • Trademarks for ELISA brands and kits
  • Patent and trademark filing trends

Enzyme-Linked Immunosorbent Assays Market REPORT HIGHLIGHTS

AspectsDetails
Study Period 2018-2032
Base Year 2023
Estimated Year 2024
Forecast Period2024-2032
Historical Period2018-2023
Growth RateCAGR of 19.5% from 2018-2032
Segmentation
    • By Test Type
      • Direct ELISA
      • Sandwich ELISA
      • Competitive ELISA
      • Reverse ELISA
    • By Application
      • Immunology
      • Inflammation
      • Infectious Diseases
      • Cancer
      • Protein Quantification
    • By End User
      • Hospitals
      • Clinical Laboratories
      • Pharmaceutical & Biotechnology Companies
      • Research & Academic Institutions
  • By Geography
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Netherlands
      • Switzerland
      • Poland
      • Sweden
      • Belgium
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
      • Singapore
      • Malaysia
      • Indonesia
      • Thailand
      • Philippines
      • New Zealand
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Chile
      • Colombia
      • Peru
    • MEA
      • UAE
      • Saudi Arabia
      • South Africa
      • Egypt
      • Turkey
      • Israel
      • Nigeria
      • Kenya

Frequently Asked Questions

Table Of Content
  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Introduction
  3. 3. Market Dynamics
    • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1. "Technological Advancements and Development of Procedure-Specific Surgical Robotic System Is Anticipated to Drive the Market"
      • 3.3. Market Restrains
        • 3.3.1. Alternatives Used for Diagnosis of CT and MRI to Limit Market Growth
      • 3.4. Market Trends
        • 3.4.1. Shift of Healthcare Providers from Medication to Electrical Stimulation for Treatment of Neurological Disorders to Fuel the Market
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  5. 5. Global Enzyme-Linked Immunosorbent Assays Market Analysis, Insights and Forecast, 2018-2030
    • 5.1. Market Analysis, Insights and Forecast - by Test Type
      • 5.1.1. Direct ELISA
      • 5.1.2. Sandwich ELISA
      • 5.1.3. Competitive ELISA
      • 5.1.4. Reverse ELISA
    • 5.2. Market Analysis, Insights and Forecast - by Application
      • 5.2.1. Immunology
      • 5.2.2. Inflammation
      • 5.2.3. Infectious Diseases
      • 5.2.4. Cancer
      • 5.2.5. Protein Quantification
    • 5.3. Market Analysis, Insights and Forecast - by End User
      • 5.3.1. Hospitals
      • 5.3.2. Clinical Laboratories
      • 5.3.3. Pharmaceutical & Biotechnology Companies
      • 5.3.4. Research & Academic Institutions
    • 5.4. Market Analysis, Insights and Forecast - by Region
      • 5.4.1. North America
      • 5.4.2. Europe
      • 5.4.3. Asia Pacific
      • 5.4.4. Latin America
      • 5.4.5. MEA
  6. 6. North America Enzyme-Linked Immunosorbent Assays Market Analysis, Insights and Forecast, 2018-2030
    • 6.1. Market Analysis, Insights and Forecast - by Test Type
      • 6.1.1. Direct ELISA
      • 6.1.2. Sandwich ELISA
      • 6.1.3. Competitive ELISA
      • 6.1.4. Reverse ELISA
    • 6.2. Market Analysis, Insights and Forecast - by Application
      • 6.2.1. Immunology
      • 6.2.2. Inflammation
      • 6.2.3. Infectious Diseases
      • 6.2.4. Cancer
      • 6.2.5. Protein Quantification
    • 6.3. Market Analysis, Insights and Forecast - by End User
      • 6.3.1. Hospitals
      • 6.3.2. Clinical Laboratories
      • 6.3.3. Pharmaceutical & Biotechnology Companies
      • 6.3.4. Research & Academic Institutions
  7. 7. Europe Enzyme-Linked Immunosorbent Assays Market Analysis, Insights and Forecast, 2018-2030
    • 7.1. Market Analysis, Insights and Forecast - by Test Type
      • 7.1.1. Direct ELISA
      • 7.1.2. Sandwich ELISA
      • 7.1.3. Competitive ELISA
      • 7.1.4. Reverse ELISA
    • 7.2. Market Analysis, Insights and Forecast - by Application
      • 7.2.1. Immunology
      • 7.2.2. Inflammation
      • 7.2.3. Infectious Diseases
      • 7.2.4. Cancer
      • 7.2.5. Protein Quantification
    • 7.3. Market Analysis, Insights and Forecast - by End User
      • 7.3.1. Hospitals
      • 7.3.2. Clinical Laboratories
      • 7.3.3. Pharmaceutical & Biotechnology Companies
      • 7.3.4. Research & Academic Institutions
  8. 8. Asia Pacific Enzyme-Linked Immunosorbent Assays Market Analysis, Insights and Forecast, 2018-2030
    • 8.1. Market Analysis, Insights and Forecast - by Test Type
      • 8.1.1. Direct ELISA
      • 8.1.2. Sandwich ELISA
      • 8.1.3. Competitive ELISA
      • 8.1.4. Reverse ELISA
    • 8.2. Market Analysis, Insights and Forecast - by Application
      • 8.2.1. Immunology
      • 8.2.2. Inflammation
      • 8.2.3. Infectious Diseases
      • 8.2.4. Cancer
      • 8.2.5. Protein Quantification
    • 8.3. Market Analysis, Insights and Forecast - by End User
      • 8.3.1. Hospitals
      • 8.3.2. Clinical Laboratories
      • 8.3.3. Pharmaceutical & Biotechnology Companies
      • 8.3.4. Research & Academic Institutions
  9. 9. Latin America Enzyme-Linked Immunosorbent Assays Market Analysis, Insights and Forecast, 2018-2030
    • 9.1. Market Analysis, Insights and Forecast - by Test Type
      • 9.1.1. Direct ELISA
      • 9.1.2. Sandwich ELISA
      • 9.1.3. Competitive ELISA
      • 9.1.4. Reverse ELISA
    • 9.2. Market Analysis, Insights and Forecast - by Application
      • 9.2.1. Immunology
      • 9.2.2. Inflammation
      • 9.2.3. Infectious Diseases
      • 9.2.4. Cancer
      • 9.2.5. Protein Quantification
    • 9.3. Market Analysis, Insights and Forecast - by End User
      • 9.3.1. Hospitals
      • 9.3.2. Clinical Laboratories
      • 9.3.3. Pharmaceutical & Biotechnology Companies
      • 9.3.4. Research & Academic Institutions
  10. 10. MEA Enzyme-Linked Immunosorbent Assays Market Analysis, Insights and Forecast, 2018-2030
    • 10.1. Market Analysis, Insights and Forecast - by Test Type
      • 10.1.1. Direct ELISA
      • 10.1.2. Sandwich ELISA
      • 10.1.3. Competitive ELISA
      • 10.1.4. Reverse ELISA
    • 10.2. Market Analysis, Insights and Forecast - by Application
      • 10.2.1. Immunology
      • 10.2.2. Inflammation
      • 10.2.3. Infectious Diseases
      • 10.2.4. Cancer
      • 10.2.5. Protein Quantification
    • 10.3. Market Analysis, Insights and Forecast - by End User
      • 10.3.1. Hospitals
      • 10.3.2. Clinical Laboratories
      • 10.3.3. Pharmaceutical & Biotechnology Companies
      • 10.3.4. Research & Academic Institutions
  11. 11. North America Enzyme-Linked Immunosorbent Assays Market Analysis, Insights and Forecast, 2018-2030
      • 11.1. Market Analysis, Insights and Forecast - By Test Type
        • 11.1.1 Direct ELISA
        • 11.1.2 Sandwich ELISA
        • 11.1.3 Competitive ELISA
        • 11.1.4 Reverse ELISA
      • 11.2. Market Analysis, Insights and Forecast - By Application
        • 11.2.1 Immunology
        • 11.2.2 Inflammation
        • 11.2.3 Infectious Diseases
        • 11.2.4 Cancer
        • 11.2.5 Protein Quantification
      • 11.3. Market Analysis, Insights and Forecast - By End User
        • 11.3.1 Hospitals
        • 11.3.2 Clinical Laboratories
        • 11.3.3 Pharmaceutical & Biotechnology Companies
        • 11.3.4 Research & Academic Institutions
      • 11.4. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 11.4.1 United States
        • 11.4.2 Canada
        • 11.4.3 Mexico
        • 11.4.4 Rest of North America
  12. 12. Asia Pacific Enzyme-Linked Immunosorbent Assays Market Analysis, Insights and Forecast, 2018-2030
      • 12.1. Market Analysis, Insights and Forecast - By Test Type
        • 12.1.1 Direct ELISA
        • 12.1.2 Sandwich ELISA
        • 12.1.3 Competitive ELISA
        • 12.1.4 Reverse ELISA
      • 12.2. Market Analysis, Insights and Forecast - By Application
        • 12.2.1 Immunology
        • 12.2.2 Inflammation
        • 12.2.3 Infectious Diseases
        • 12.2.4 Cancer
        • 12.2.5 Protein Quantification
      • 12.3. Market Analysis, Insights and Forecast - By End User
        • 12.3.1 Hospitals
        • 12.3.2 Clinical Laboratories
        • 12.3.3 Pharmaceutical & Biotechnology Companies
        • 12.3.4 Research & Academic Institutions
      • 12.4. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 12.4.1 China
        • 12.4.2 Japan
        • 12.4.3 India
        • 12.4.4 South Korea
        • 12.4.5 Taiwan
        • 12.4.6 Australia
        • 12.4.7 Rest of Asia-Pacific
  13. 13. Middle East & Africa Enzyme-Linked Immunosorbent Assays Market Analysis, Insights and Forecast, 2018-2030
      • 13.1. Market Analysis, Insights and Forecast - By Test Type
        • 13.1.1 Direct ELISA
        • 13.1.2 Sandwich ELISA
        • 13.1.3 Competitive ELISA
        • 13.1.4 Reverse ELISA
      • 13.2. Market Analysis, Insights and Forecast - By Application
        • 13.2.1 Immunology
        • 13.2.2 Inflammation
        • 13.2.3 Infectious Diseases
        • 13.2.4 Cancer
        • 13.2.5 Protein Quantification
      • 13.3. Market Analysis, Insights and Forecast - By End User
        • 13.3.1 Hospitals
        • 13.3.2 Clinical Laboratories
        • 13.3.3 Pharmaceutical & Biotechnology Companies
        • 13.3.4 Research & Academic Institutions
      • 13.4. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 13.4.1 UAE
        • 13.4.2 South Africa
        • 13.4.3 Saudi Arabia
        • 13.4.4 Rest of MEA
  14. 14. Europe Enzyme-Linked Immunosorbent Assays Market Analysis, Insights and Forecast, 2018-2030
      • 14.1. Market Analysis, Insights and Forecast - By Test Type
        • 14.1.1 Direct ELISA
        • 14.1.2 Sandwich ELISA
        • 14.1.3 Competitive ELISA
        • 14.1.4 Reverse ELISA
      • 14.2. Market Analysis, Insights and Forecast - By Application
        • 14.2.1 Immunology
        • 14.2.2 Inflammation
        • 14.2.3 Infectious Diseases
        • 14.2.4 Cancer
        • 14.2.5 Protein Quantification
      • 14.3. Market Analysis, Insights and Forecast - By End User
        • 14.3.1 Hospitals
        • 14.3.2 Clinical Laboratories
        • 14.3.3 Pharmaceutical & Biotechnology Companies
        • 14.3.4 Research & Academic Institutions
      • 14.4. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 14.4.1 Germany
        • 14.4.2 France
        • 14.4.3 Italy
        • 14.4.4 United Kingdom
        • 14.4.5 Netherlands
        • 14.4.6 Rest of Europe
  15. 15. South America Enzyme-Linked Immunosorbent Assays Market Analysis, Insights and Forecast, 2018-2030
      • 15.1. Market Analysis, Insights and Forecast - By Test Type
        • 15.1.1 Direct ELISA
        • 15.1.2 Sandwich ELISA
        • 15.1.3 Competitive ELISA
        • 15.1.4 Reverse ELISA
      • 15.2. Market Analysis, Insights and Forecast - By Application
        • 15.2.1 Immunology
        • 15.2.2 Inflammation
        • 15.2.3 Infectious Diseases
        • 15.2.4 Cancer
        • 15.2.5 Protein Quantification
      • 15.3. Market Analysis, Insights and Forecast - By End User
        • 15.3.1 Hospitals
        • 15.3.2 Clinical Laboratories
        • 15.3.3 Pharmaceutical & Biotechnology Companies
        • 15.3.4 Research & Academic Institutions
      • 15.4. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 15.4.1 Brazil
        • 15.4.2 Argentina
        • 15.4.3 Rest of South America
  16. 16. Competitive Analysis
    • 16.1. Global Market Share Analysis 2023
      • 16.2. Company Profiles
        • 16.2.1 Some of the major companies that are present in the global Enzyme-Linked Immunosorbent Assays (ELISA) market are Thermo Fisher Scientific. Inc.
          • 16.2.1.1. Overview
          • 16.2.1.2. Products
          • 16.2.1.3. SWOT Analysis
          • 16.2.1.4. Recent Developments
          • 16.2.1.5. Financials (Based on Availability)
        • 16.2.2 Bio-Rad Laboratories
          • 16.2.2.1. Overview
          • 16.2.2.2. Products
          • 16.2.2.3. SWOT Analysis
          • 16.2.2.4. Recent Developments
          • 16.2.2.5. Financials (Based on Availability)
        • 16.2.3 Inc.
          • 16.2.3.1. Overview
          • 16.2.3.2. Products
          • 16.2.3.3. SWOT Analysis
          • 16.2.3.4. Recent Developments
          • 16.2.3.5. Financials (Based on Availability)
        • 16.2.4 Ortho-Clinical Diagnostics
          • 16.2.4.1. Overview
          • 16.2.4.2. Products
          • 16.2.4.3. SWOT Analysis
          • 16.2.4.4. Recent Developments
          • 16.2.4.5. Financials (Based on Availability)
        • 16.2.5 ZEUS Scientific
          • 16.2.5.1. Overview
          • 16.2.5.2. Products
          • 16.2.5.3. SWOT Analysis
          • 16.2.5.4. Recent Developments
          • 16.2.5.5. Financials (Based on Availability)
        • 16.2.6 Inc.
          • 16.2.6.1. Overview
          • 16.2.6.2. Products
          • 16.2.6.3. SWOT Analysis
          • 16.2.6.4. Recent Developments
          • 16.2.6.5. Financials (Based on Availability)
        • 16.2.7 BD
          • 16.2.7.1. Overview
          • 16.2.7.2. Products
          • 16.2.7.3. SWOT Analysis
          • 16.2.7.4. Recent Developments
          • 16.2.7.5. Financials (Based on Availability)
        • 16.2.8 ALPCO
          • 16.2.8.1. Overview
          • 16.2.8.2. Products
          • 16.2.8.3. SWOT Analysis
          • 16.2.8.4. Recent Developments
          • 16.2.8.5. Financials (Based on Availability)
        • 16.2.9 bioMérieux SA and other players.
          • 16.2.9.1. Overview
          • 16.2.9.2. Products
          • 16.2.9.3. SWOT Analysis
          • 16.2.9.4. Recent Developments
          • 16.2.9.5. Financials (Based on Availability)
List of Figures
  1. Figure 1: Global Enzyme-Linked Immunosorbent Assays Market Revenue Breakdown (USD billion, %) by Region 2023 & 2031
  2. Figure 2: Global Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Test Type 2023 & 2031
  3. Figure 3: Global Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Test Type 2023 & 2031
  4. Figure 4: Global Enzyme-Linked Immunosorbent Assays Market Forecast (USD billion), by Direct ELISA 2020 & 2031
  5. Figure 5: Global Enzyme-Linked Immunosorbent Assays Market Forecast (USD billion), by Sandwich ELISA 2020 & 2031
  6. Figure 6: Global Enzyme-Linked Immunosorbent Assays Market Forecast (USD billion), by Competitive ELISA 2020 & 2031
  7. Figure 7: Global Enzyme-Linked Immunosorbent Assays Market Forecast (USD billion), by Reverse ELISA 2020 & 2031
  8. Figure 8: Global Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Application 2023 & 2031
  9. Figure 9: Global Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Application 2023 & 2031
  10. Figure 10: Global Enzyme-Linked Immunosorbent Assays Market Forecast (USD billion), by Immunology 2020 & 2031
  11. Figure 11: Global Enzyme-Linked Immunosorbent Assays Market Forecast (USD billion), by Inflammation 2020 & 2031
  12. Figure 12: Global Enzyme-Linked Immunosorbent Assays Market Forecast (USD billion), by Infectious Diseases 2020 & 2031
  13. Figure 13: Global Enzyme-Linked Immunosorbent Assays Market Forecast (USD billion), by Cancer 2020 & 2031
  14. Figure 14: Global Enzyme-Linked Immunosorbent Assays Market Forecast (USD billion), by Protein Quantification 2020 & 2031
  15. Figure 15: Global Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by End User 2023 & 2031
  16. Figure 16: Global Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by End User 2023 & 2031
  17. Figure 17: Global Enzyme-Linked Immunosorbent Assays Market Forecast (USD billion), by Hospitals 2020 & 2031
  18. Figure 18: Global Enzyme-Linked Immunosorbent Assays Market Forecast (USD billion), by Clinical Laboratories 2020 & 2031
  19. Figure 19: Global Enzyme-Linked Immunosorbent Assays Market Forecast (USD billion), by Pharmaceutical & Biotechnology Companies 2020 & 2031
  20. Figure 20: Global Enzyme-Linked Immunosorbent Assays Market Forecast (USD billion), by Research & Academic Institutions 2020 & 2031
  21. Figure 21: Global Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Region 2023 & 2031
  22. Figure 22: Global Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Region 2023 & 2031
  23. Figure 23: North America Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Test Type 2023 & 2031
  24. Figure 24: North America Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Test Type 2023 & 2031
  25. Figure 25: North America Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Application 2023 & 2031
  26. Figure 26: North America Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Application 2023 & 2031
  27. Figure 27: North America Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by End User 2023 & 2031
  28. Figure 28: North America Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by End User 2023 & 2031
  29. Figure 29: North America Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Country 2023 & 2031
  30. Figure 30: North America Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Country 2023 & 2031
  31. Figure 31: Asia Pacific Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Test Type 2023 & 2031
  32. Figure 32: Asia Pacific Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Test Type 2023 & 2031
  33. Figure 33: Asia Pacific Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Application 2023 & 2031
  34. Figure 34: Asia Pacific Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Application 2023 & 2031
  35. Figure 35: Asia Pacific Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by End User 2023 & 2031
  36. Figure 36: Asia Pacific Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by End User 2023 & 2031
  37. Figure 37: Asia Pacific Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Country 2023 & 2031
  38. Figure 38: Asia Pacific Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Country 2023 & 2031
  39. Figure 39: Middle East & Africa Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Test Type 2023 & 2031
  40. Figure 40: Middle East & Africa Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Test Type 2023 & 2031
  41. Figure 41: Middle East & Africa Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Application 2023 & 2031
  42. Figure 42: Middle East & Africa Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Application 2023 & 2031
  43. Figure 43: Middle East & Africa Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by End User 2023 & 2031
  44. Figure 44: Middle East & Africa Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by End User 2023 & 2031
  45. Figure 45: Middle East & Africa Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Country 2023 & 2031
  46. Figure 46: Middle East & Africa Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Country 2023 & 2031
  47. Figure 47: Europe Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Test Type 2023 & 2031
  48. Figure 48: Europe Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Test Type 2023 & 2031
  49. Figure 49: Europe Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Application 2023 & 2031
  50. Figure 50: Europe Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Application 2023 & 2031
  51. Figure 51: Europe Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by End User 2023 & 2031
  52. Figure 52: Europe Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by End User 2023 & 2031
  53. Figure 53: Europe Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Country 2023 & 2031
  54. Figure 54: Europe Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Country 2023 & 2031
  55. Figure 55: South America Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Test Type 2023 & 2031
  56. Figure 56: South America Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Test Type 2023 & 2031
  57. Figure 57: South America Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Application 2023 & 2031
  58. Figure 58: South America Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Application 2023 & 2031
  59. Figure 59: South America Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by End User 2023 & 2031
  60. Figure 60: South America Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by End User 2023 & 2031
  61. Figure 61: South America Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Country 2023 & 2031
  62. Figure 62: South America Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Country 2023 & 2031
  63. Figure 63: North America Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Test Type 2023 & 2031
  64. Figure 64: North America Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Test Type 2023 & 2031
  65. Figure 65: North America Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Application 2023 & 2031
  66. Figure 66: North America Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Application 2023 & 2031
  67. Figure 67: North America Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by End User 2023 & 2031
  68. Figure 68: North America Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by End User 2023 & 2031
  69. Figure 69: North America Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Country 2023 & 2031
  70. Figure 70: North America Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Country 2023 & 2031
  71. Figure 71: Europe Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Test Type 2023 & 2031
  72. Figure 72: Europe Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Test Type 2023 & 2031
  73. Figure 73: Europe Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Application 2023 & 2031
  74. Figure 74: Europe Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Application 2023 & 2031
  75. Figure 75: Europe Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by End User 2023 & 2031
  76. Figure 76: Europe Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by End User 2023 & 2031
  77. Figure 77: Europe Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Country 2023 & 2031
  78. Figure 78: Europe Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Country 2023 & 2031
  79. Figure 79: Asia Pacific Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Test Type 2023 & 2031
  80. Figure 80: Asia Pacific Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Test Type 2023 & 2031
  81. Figure 81: Asia Pacific Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Application 2023 & 2031
  82. Figure 82: Asia Pacific Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Application 2023 & 2031
  83. Figure 83: Asia Pacific Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by End User 2023 & 2031
  84. Figure 84: Asia Pacific Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by End User 2023 & 2031
  85. Figure 85: Asia Pacific Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Country 2023 & 2031
  86. Figure 86: Asia Pacific Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Country 2023 & 2031
  87. Figure 87: Latin America Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Test Type 2023 & 2031
  88. Figure 88: Latin America Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Test Type 2023 & 2031
  89. Figure 89: Latin America Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Application 2023 & 2031
  90. Figure 90: Latin America Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Application 2023 & 2031
  91. Figure 91: Latin America Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by End User 2023 & 2031
  92. Figure 92: Latin America Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by End User 2023 & 2031
  93. Figure 93: Latin America Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Country 2023 & 2031
  94. Figure 94: Latin America Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Country 2023 & 2031
  95. Figure 95: MEA Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Test Type 2023 & 2031
  96. Figure 96: MEA Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Test Type 2023 & 2031
  97. Figure 97: MEA Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Application 2023 & 2031
  98. Figure 98: MEA Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Application 2023 & 2031
  99. Figure 99: MEA Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by End User 2023 & 2031
  100. Figure 100: MEA Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by End User 2023 & 2031
  101. Figure 101: MEA Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion), by Country 2023 & 2031
  102. Figure 102: MEA Enzyme-Linked Immunosorbent Assays Market Revenue Share (%), by Country 2023 & 2031
List of Tables
  1. Table 1: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Test Type 2018 & 2031
  2. Table 2: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Application 2018 & 2031
  3. Table 3: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by End User 2018 & 2031
  4. Table 4: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Region 2018 & 2031
  5. Table 5: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Test Type 2018 & 2031
  6. Table 6: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Application 2018 & 2031
  7. Table 7: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by End User 2018 & 2031
  8. Table 8: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Region 2018 & 2031
  9. Table 9: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Test Type 2018 & 2031
  10. Table 10: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Application 2018 & 2031
  11. Table 11: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by End User 2018 & 2031
  12. Table 12: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Country 2018 & 2031
  13. Table 13: United States Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  14. Table 14: Canada Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  15. Table 15: Mexico Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  16. Table 16: Rest of North America Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  17. Table 17: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Test Type 2018 & 2031
  18. Table 18: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Application 2018 & 2031
  19. Table 19: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by End User 2018 & 2031
  20. Table 20: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Country 2018 & 2031
  21. Table 21: China Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  22. Table 22: Japan Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  23. Table 23: India Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  24. Table 24: South Korea Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  25. Table 25: Taiwan Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  26. Table 26: Australia Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  27. Table 27: Rest of Asia-Pacific Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  28. Table 28: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Test Type 2018 & 2031
  29. Table 29: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Application 2018 & 2031
  30. Table 30: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by End User 2018 & 2031
  31. Table 31: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Country 2018 & 2031
  32. Table 32: UAE Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  33. Table 33: South Africa Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  34. Table 34: Saudi Arabia Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  35. Table 35: Rest of MEA Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  36. Table 36: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Test Type 2018 & 2031
  37. Table 37: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Application 2018 & 2031
  38. Table 38: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by End User 2018 & 2031
  39. Table 39: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Country 2018 & 2031
  40. Table 40: Germany Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  41. Table 41: France Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  42. Table 42: Italy Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  43. Table 43: United Kingdom Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  44. Table 44: Netherlands Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  45. Table 45: Rest of Europe Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  46. Table 46: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Test Type 2018 & 2031
  47. Table 47: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Application 2018 & 2031
  48. Table 48: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by End User 2018 & 2031
  49. Table 49: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Country 2018 & 2031
  50. Table 50: Brazil Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  51. Table 51: Argentina Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  52. Table 52: Rest of South America Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  53. Table 53: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Test Type 2018 & 2031
  54. Table 54: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Application 2018 & 2031
  55. Table 55: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by End User 2018 & 2031
  56. Table 56: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Country 2018 & 2031
  57. Table 57: U.S. Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  58. Table 58: Canada Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  59. Table 59: Mexico Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  60. Table 60: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Test Type 2018 & 2031
  61. Table 61: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Application 2018 & 2031
  62. Table 62: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by End User 2018 & 2031
  63. Table 63: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Country 2018 & 2031
  64. Table 64: UK Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  65. Table 65: Germany Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  66. Table 66: France Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  67. Table 67: Italy Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  68. Table 68: Spain Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  69. Table 69: Russia Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  70. Table 70: Netherlands Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  71. Table 71: Switzerland Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  72. Table 72: Poland Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  73. Table 73: Sweden Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  74. Table 74: Belgium Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  75. Table 75: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Test Type 2018 & 2031
  76. Table 76: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Application 2018 & 2031
  77. Table 77: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by End User 2018 & 2031
  78. Table 78: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Country 2018 & 2031
  79. Table 79: China Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  80. Table 80: India Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  81. Table 81: Japan Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  82. Table 82: South Korea Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  83. Table 83: Australia Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  84. Table 84: Singapore Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  85. Table 85: Malaysia Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  86. Table 86: Indonesia Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  87. Table 87: Thailand Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  88. Table 88: Philippines Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  89. Table 89: New Zealand Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  90. Table 90: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Test Type 2018 & 2031
  91. Table 91: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Application 2018 & 2031
  92. Table 92: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by End User 2018 & 2031
  93. Table 93: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Country 2018 & 2031
  94. Table 94: Brazil Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  95. Table 95: Mexico Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  96. Table 96: Argentina Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  97. Table 97: Chile Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  98. Table 98: Colombia Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  99. Table 99: Peru Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  100. Table 100: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Test Type 2018 & 2031
  101. Table 101: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Application 2018 & 2031
  102. Table 102: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by End User 2018 & 2031
  103. Table 103: Global Enzyme-Linked Immunosorbent Assays Market Revenue USD billion Forecast, by Country 2018 & 2031
  104. Table 104: UAE Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  105. Table 105: Saudi Arabia Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  106. Table 106: South Africa Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  107. Table 107: Egypt Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  108. Table 108: Turkey Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  109. Table 109: Israel Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  110. Table 110: Nigeria Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  111. Table 111: Kenya Enzyme-Linked Immunosorbent Assays Market Revenue (USD billion) Forecast, by Application 2018 & 2031
AspectsDetails
Study Period 2018-2032
Base Year 2023
Estimated Year 2024
Forecast Period2024-2032
Historical Period2018-2023
Growth RateCAGR of 19.5% from 2018-2032
Segmentation
    • By Test Type
      • Direct ELISA
      • Sandwich ELISA
      • Competitive ELISA
      • Reverse ELISA
    • By Application
      • Immunology
      • Inflammation
      • Infectious Diseases
      • Cancer
      • Protein Quantification
    • By End User
      • Hospitals
      • Clinical Laboratories
      • Pharmaceutical & Biotechnology Companies
      • Research & Academic Institutions
  • By Geography
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Netherlands
      • Switzerland
      • Poland
      • Sweden
      • Belgium
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
      • Singapore
      • Malaysia
      • Indonesia
      • Thailand
      • Philippines
      • New Zealand
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Chile
      • Colombia
      • Peru
    • MEA
      • UAE
      • Saudi Arabia
      • South Africa
      • Egypt
      • Turkey
      • Israel
      • Nigeria
      • Kenya

STEP 1 - Identification of Relevant Samples Size from Population Database

Step Chart
bar chart
method chart

STEP 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

approach chart
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segemnts, product and application.

Note* : In applicable scenarios

STEP 3 - Data Sources

Primary Research

  • Web Analytics
  • Survey Reports
  • Research Institute
  • Latest Research Reports
  • Opinion Leaders

Secondary Research

  • Annual Reports
  • White Paper
  • Latest Press Release
  • Industry Association
  • Paid Database
  • Investor Presentations
approach chart

STEP 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally after gathering mix and scattered data from wide range of sources, data is triangull- ated and correlated to come up with estimated figures which are further validated through primary mediums, or industry experts, opinion leader.
Get Free Sample
Hover animation image
 Pre Order Enquiry Request discount

Pricing

$4850
Single User License:
  • Only one user can access this report at time
  • users are not allowed to take a print out of the report PDF
$5850
Multi User License:
  • The report will be emailed to you in PDF format.
  • This is a multi-user license, allowing 1-10 employees within your organisation to access the report.
$6850
Corporate User License:
  • Sharable and Printable among all employees of your organization
  • Excel Raw data with access to full quantitative & financial market insights
  • Customization at no additional cost within the scope of the report
  • Graphs and Charts can be used during presentation
BUY NOW
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo

Tailored for you

  • In-depth Analysis Tailored to Specified Regions or Segments
  • Company Profiles Customized to User Preferences
  • Comprehensive Insights Focused on Specific Segments or Regions
  • Customized Evaluation of Competitive Landscape to Meet Your Needs
  • Tailored Customization to Address Other Specific Requirements
Ask for customization

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report

quotation
avatar

Jared Wan

Analyst at Providence Strategic Partners at Petaling Jaya

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

quotation
avatar

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

The response was good, and I got what I was looking for as far as the report. Thank you for that.

quotation
avatar

Erik Perison

US TPS Business Development Manager at Thermon

About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

+1 2017933837

+44 20 7097 9277

sales@marketresearchforecast.com

  • Home
  • About Us
  • Industries
    • Healthcare
    • Chemicals & Materials
    • Information & Technology
    • Machinery & Equipment
    • Energy & Power
    • Aerospace & Defense
    • Automotive & Transportation
    • Food & Beverages
    • Agriculture
    • Consumer Goods
    • Semiconductor & Electronics
    • Packaging
    • COVID-19 Analysis
  • Services
  • Contact
MRF logo
  • Home
  • About Us
  • Industries
    • Healthcare
    • Chemicals & Materials
    • Information & Technology
    • Machinery & Equipment
    • Energy & Power
    • Aerospace & Defense
    • Automotive & Transportation
    • Food & Beverages
    • Agriculture
    • Consumer Goods
    • Semiconductor & Electronics
    • Packaging
    • COVID-19 Analysis
  • Services
  • Contact
sales@marketresearchforecast.com

Business Address

Head Office

Office no. A 5010, fifth floor, Solitaire Business Hub, Near Phoenix mall, Pune, Maharashtra 411014

Contact Information

Craig Francis

Business Development Head

+1 940 441 3937

sales@marketresearchforecast.com

Extra Links

AboutContactsTestimonials
ServicesCareer

Subscribe

Get the latest updates and offers.

PackagingHealthcareAgricultureEnergy & PowerConsumer GoodsFood & BeveragesCOVID-19 AnalysisAerospace & DefenseChemicals & MaterialsMachinery & EquipmentInformation & TechnologyAutomotive & TransportationSemiconductor & Electronics

© 2024 AMA Research. All rights reserved

Privacy Policy
Terms and Conditions
FAQ

Related Reports

report thumbnailFemale Sexual Dysfunction Treatment Market

Female Sexual Dysfunction Treatment Market 2024 to Grow at 1...

report thumbnailUrinary Drainage Bags Market

Urinary Drainage Bags Market Analysis Report 2024: Market to...

report thumbnailGuidewires Market

Guidewires Market 2024 to Grow at 21.2 CAGR with XX USD mill...

report thumbnailAsia Pacific In-vitro Diagnostics Market

Asia Pacific In-vitro Diagnostics Market Analysis 2024 and F...

report thumbnailBrain Implants Market

Brain Implants Market Charting Growth Trajectories: Analysis...

report thumbnailContinuous Renal Replacement Therapy (CRRT) Market

Continuous Renal Replacement Therapy (CRRT) Market Future-pr...

report thumbnailFoot Prosthetics Market

Foot Prosthetics Market 2024 to Grow at 6.6 CAGR with 588.1 ...

report thumbnailImmunoglobulins Market

Immunoglobulins Market Decade Long Trends, Analysis and Fore...

report thumbnailNegative Pressure Wound Therapy (NPWT) Market

Negative Pressure Wound Therapy (NPWT) Market Is Set To Reac...

report thumbnailViral Vaccines Market

Viral Vaccines Market Unlocking Growth Opportunities: Analys...

report thumbnailNeurovascular Devices/Interventional Neurology Market

Neurovascular Devices/Interventional Neurology Market 2024 t...

report thumbnailU.S. Normal Saline for Parenteral Use Market

U.S. Normal Saline for Parenteral Use Market  Analysis Repor...

report thumbnailHealthcare Predictive Analytics Market

Healthcare Predictive Analytics Market Decade Long Trends, A...

report thumbnailStomach-Gastric- Cancer- Treatment Market

Stomach-Gastric- Cancer- Treatment Market Decade Long Trends...

report thumbnailBiomarkers Market

Biomarkers Market Report Probes the 38.41 USD billion Size, ...

report thumbnailAntiepileptic Drug Market

Antiepileptic Drug Market 2024-2032 Analysis: Trends, Compet...

report thumbnailSurgical Stapling Devices Market

Surgical Stapling Devices Market Insightful Analysis: Trends...

report thumbnailUrinary Catheter Market

Urinary Catheter Market Report Probes the 2.56 USD Billion S...

report thumbnailAdult Diapers Market

Adult Diapers Market Is Set To Reach 11.55 USD Billion By 20...

report thumbnailSpectacles Market

Spectacles Market 2024 to Grow at 5.7 CAGR with 91.56 USD bi...